A Revised Classification System and Recommendations From the Baltimore Consensus Meeting for Neoplastic Precursor Lesions in the Pancreas
- PMID: 26559377
- PMCID: PMC4646710
- DOI: 10.1097/PAS.0000000000000533
A Revised Classification System and Recommendations From the Baltimore Consensus Meeting for Neoplastic Precursor Lesions in the Pancreas
Abstract
International experts met to discuss recent advances and to revise the 2004 recommendations for assessing and reporting precursor lesions to invasive carcinomas of the pancreas, including pancreatic intraepithelial neoplasia (PanIN), intraductal papillary mucinous neoplasm (IPMN), mucinous cystic neoplasm, and other lesions. Consensus recommendations include the following: (1) To improve concordance and to align with practical consequences, a 2-tiered system (low vs. high grade) is proposed for all precursor lesions, with the provision that the current PanIN-2 and neoplasms with intermediate-grade dysplasia now be categorized as low grade. Thus, "high-grade dysplasia" is to be reserved for only the uppermost end of the spectrum ("carcinoma in situ"-type lesions). (2) Current data indicate that PanIN of any grade at a margin of a resected pancreas with invasive carcinoma does not have prognostic implications; the clinical significance of dysplasia at a margin in a resected pancreas with IPMN lacking invasive carcinoma remains to be determined. (3) Intraductal lesions 0.5 to 1 cm can be either large PanINs or small IPMNs. The term "incipient IPMN" should be reserved for lesions in this size with intestinal or oncocytic papillae or GNAS mutations. (4) Measurement of the distance between an IPMN and invasive carcinoma and sampling of intervening tissue are recommended to assess concomitant versus associated status. Conceptually, concomitant invasive carcinoma (in contrast with the "associated" group) ought to be genetically distinct from an IPMN elsewhere in the gland. (5) "Intraductal spread of invasive carcinoma" (aka, "colonization") is recommended to describe lesions of invasive carcinoma invading back into and extending along the ductal system, which may morphologically mimic high-grade PanIN or even IPMN. (6) "Simple mucinous cyst" is recommended to describe cysts >1 cm having gastric-type flat mucinous lining at most minimal atypia without ovarian-type stroma to distinguish them from IPMN. (7) Human lesions resembling the acinar to ductal metaplasia and atypical flat lesions of genetically engineered mouse models exist and may reflect an alternate pathway of carcinogenesis; however, their biological significance requires further study. These revised recommendations are expected to improve our management and understanding of precursor lesions in the pancreas.
Conflict of interest statement
Figures







Similar articles
-
Current recommendations for surveillance and surgery of intraductal papillary mucinous neoplasms may overlook some patients with cancer.J Gastrointest Surg. 2015 Feb;19(2):258-65. doi: 10.1007/s11605-014-2693-z. Epub 2014 Nov 6. J Gastrointest Surg. 2015. PMID: 25373706 Free PMC article.
-
GNAS sequencing identifies IPMN-specific mutations in a subgroup of diminutive pancreatic cysts referred to as "incipient IPMNs".Am J Surg Pathol. 2014 Mar;38(3):360-3. doi: 10.1097/PAS.0000000000000117. Am J Surg Pathol. 2014. PMID: 24525507 Free PMC article.
-
Cystic neoplasia of the pancreas: pathology and biology.J Gastrointest Surg. 2008 Mar;12(3):401-4. doi: 10.1007/s11605-007-0348-z. Epub 2007 Oct 24. J Gastrointest Surg. 2008. PMID: 17957438 Review.
-
Targeted next-generation sequencing of cancer genes dissects the molecular profiles of intraductal papillary neoplasms of the pancreas.J Pathol. 2014 Jul;233(3):217-27. doi: 10.1002/path.4344. J Pathol. 2014. PMID: 24604757 Free PMC article.
-
Current understanding of precursors to pancreatic cancer.J Hepatobiliary Pancreat Surg. 2007;14(3):217-23. doi: 10.1007/s00534-006-1165-6. Epub 2007 May 29. J Hepatobiliary Pancreat Surg. 2007. PMID: 17520195 Review.
Cited by
-
Clinical development of a blood biomarker using apolipoprotein-A2 isoforms for early detection of pancreatic cancer.J Gastroenterol. 2024 Mar;59(3):263-278. doi: 10.1007/s00535-023-02072-w. Epub 2024 Jan 23. J Gastroenterol. 2024. PMID: 38261000 Free PMC article.
-
Ductal Dilatation of ≥5 mm in Intraductal Papillary Mucinous Neoplasm Should Trigger the Consideration for Pancreatectomy: A Meta-Analysis and Systematic Review of Resected Cases.Cancers (Basel). 2021 Apr 22;13(9):2031. doi: 10.3390/cancers13092031. Cancers (Basel). 2021. PMID: 33922344 Free PMC article. Review.
-
Improving the prognosis of pancreatic cancer: insights from epidemiology, genomic alterations, and therapeutic challenges.Front Med. 2023 Dec;17(6):1135-1169. doi: 10.1007/s11684-023-1050-6. Epub 2023 Dec 27. Front Med. 2023. PMID: 38151666 Review.
-
Minimally invasive enucleation of pancreatic tumors: The main pancreatic duct is no longer a restricted area.Heliyon. 2023 Nov 7;9(11):e21917. doi: 10.1016/j.heliyon.2023.e21917. eCollection 2023 Nov. Heliyon. 2023. PMID: 38027678 Free PMC article.
-
Clinical usefulness of tissue acquisition of pancreatic cystic lesions using an endoscopic ultrasound-guided needle for histological analysis.Endosc Int Open. 2024 Jan 30;12(1):E155-E163. doi: 10.1055/a-2240-0678. eCollection 2024 Jan. Endosc Int Open. 2024. PMID: 38292591 Free PMC article.
References
-
- Hruban RH, Adsay NV, Albores-Saavedra J, et al. Pancreatic intraepithelial neoplasia: a new nomenclature and classification system for pancreatic duct lesions. Am J Surg Pathol. 2001;25:579–586. - PubMed
-
- Hruban RH, Takaori K, Klimstra DS, et al. An illustrated consensus on the classification of pancreatic intraepithelial neoplasia and intraductal papillary mucinous neoplasms. Am J Surg Pathol. 2004;28:977–987. - PubMed
-
- Hruban RH, Pitman MB, Klimstra DS. Tumors of the pancreas. Washington, DC: American Registry of Pathology; 2007.
-
- Adsay NV, Fukushima N, Furukawa T, et al. Intraductal neoplasms of the pancreas. In: Bosman FT, Hruban RH, Carneiro F, et al., editors. WHO Classification of Tumours of the Digestive System. Lyon: IARC; 2010. pp. 304–313.
-
- Hruban RH, Adsay NV, Albores-Saavedra J, et al. Pathology of genetically engineered mouse models of pancreatic exocrine cancer: consensus report and recommendations. Cancer Res. 2006;66:95–106. - PubMed
Publication types
MeSH terms
Grants and funding
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical
Miscellaneous